Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Lenalidomide in Recurrent/Metastatic SCCHN
NCT01133665Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Feb 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Chicago. Started Feb 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01133665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01133665.